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There	 is	 a	 pressing	 need	 for	 new	 technologies	 that	 improve	 the	 efficacy	 and	16	
efficiency	 of	 drug	 discovery.	 Structure-based	methods	 have	 contributed	 towards	17	
this	 goal	 but	 they	 focus	 on	 predicting	 the	 binding	 affinity	 of	 protein–ligand	18	
complexes,	which	 is	 notoriously	 difficult.	We	 adopt	 an	 alternative	 approach	 that	19	




receptor.	 This	 non-equilibrium	 property	 is	 surprisingly	 effective	 in	 virtual	24	
screening	 because	 true	 ligands	 form	 more	 resilient	 interactions	 than	 decoys.	25	
Notably,	DUck	 is	orthogonal	 to	docking	and	other	 ‘thermodynamic’	methods.	We	26	



















to	 provide	 structural	 stability	 because	 they	 have	 sharp	 distance	 and	 angular	45	
dependencies.4	Their	contribution	to	the	free	energy	of	binding	(ΔGbind)	is	variable	46	
but	can	be	substantial.5	Importantly,	they	often	act	as	anchoring	points	in	protein–47	
ligand	 complexes,	 providing	 the	 minimal	 binding	 unit	 through	 one	 or	 a	 few	48	
hydrogen	 bonds	 as	 demonstrated	 for	 fragment-sized	 ligands.6,7	 We	 have	49	
previously	shown	that	certain	hydrogen	bonds	present	strong	opposition	to	small	50	
structural	distortions	and	can	act	as	kinetic	 traps	because	 the	 local	 environment	51	
hinders	 the	 transition	 from	 a	 direct	 hydrogen	 bond	 to	 a	 water-bridged	52	
interaction.8	As	an	early	unbinding	event,	rupture	of	the	so-called	water-shielded	53	
hydrogen	 bonds	 can	 influence	 the	whole	 dissociation	 process.8,9	 Taken	 together,	54	
these	 observations	 suggest	 that	 hydrogen	 bonds	 are	 the	 main	 determinants	 of	55	
structural	 stability,	 and	 lead	 us	 to	 postulate	 that	 their	 resilience	 should	 provide	56	




We	 will	 introduce	 DUck,	 a	 simplified	 computational	 procedure	 to	 calculate	 the	61	
work	 needed	 to	 break	 a	 key	 native	 contact,	 reaching	 a	 quasi-bound	 state	 (WQB).	62	
Then,	 we	 will	 show	 that	 active	 compounds	 are	 structurally	 stable	 and	 present	63	
higher	 WQB	 values	 than	 inactive	 ones.	 Finally,	 we	 demonstrate	 the	 use	 of	 this	64	
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To	 assess	 the	 hypothesis,	 we	 have	 devised	 Dynamic	 Undocking	 (DUck)	72	
simulations,	where	 a	 key	 intermolecular	hydrogen	bond	 is	pulled	 from	an	 initial	73	
distance	of	2.5	Å	(close	contact)	to	5.0	Å	(broken	contact).	In	order	to	focus	on	just	74	
one	specific	hydrogen	bond,	we	use	model	receptors	comprising	only	the	protein	75	
residues	 that	 are	within	 6	 Å	 of	 the	 given	 hydrogen	 bond	 (Figure	 1A).	 The	work	76	
necessary	to	carry	out	the	steering	process	is	monitored,	and	we	define	the	quasi-77	
bound	 (QB)	 state	 as	 the	 point	 along	 the	 simulation	 where	 the	 work	 profile	78	
presents	 the	 highest	 value.	WQB	 is	 the	 work	 necessary	 to	 depart	 from	 the	 ideal	79	
hydrogen	bond	configuration	and	reach	the	QB	state	(Figure	1B).	Notably,	this	is	a	80	
non-equilibrium	property,	and	there	is	no	reason	why	it	should	correlate	with	any	81	
measurement	 of	 binding	 affinity.	 What	 is	 more,	 as	 the	 unbound	 state	 is	 not	82	
considered,	 WQB	 cannot	 inform	 about	 the	 binding	 free	 energy.	 Instead,	 this	83	
magnitude	 solely	 indicates	 if	 the	 interaction	 under	 investigation	 gives	 rise	 to	 a	84	









bonding	 opportunities.10	 For	 CDK2,	 the	 central	 hydrogen-bond	 donor	 (NH	 of	93	
Leu83)	is	the	most	conserved	interaction	site	and	was	used	to	define	the	reaction	94	
coordinate.	 WQB	 presents	 only	 a	 weak	 correlation	 with	 binding	 affinity	95	
(Supplementary	 Figure	 2),	 but	 the	 distribution	 of	 WQB	 values	 is	 clearly	 skewed	96	
(Figure	2A	and	Supplementary	Figure	3).	Thus,	65%	of	weak	binders	(IC50	>	1	µM)	97	
present	WQB	values	below	6	kcal/mol,	while	all	strong	binders	(IC50	<	1	µM)	pass	98	
this	 threshold.	 Ligand	3FZ1,11	 is	 the	 clear	 exception	 as	 it	 presents	 an	 almost	 flat	99	
dissociation	profile	(WQB	=	0.12	kcal/mol).	This	is	explained	by	an	unsuitably	long	100	
(3.4	Å)	 interaction	with	 the	hinge	 region,	 involving	 a	methoxy	 group,	which	 is	 a	101	
poor	 hydrogen	 bond	 acceptor.4	 Instead,	 this	 unusual	 ligand	 forms	 two	 charge-102	
reinforced	hydrogen	bonds	with	Lys33	and	Asn132,	from	which	it	draws	structural	103	
stability	 (Supplementary	 Figure	 4).	 This	 shows	 that	 some	 ligands	 can	 use	104	





we	use	 the	bromodomain	and	extra-terminal	 (BET)	BRD4-BD1	as	additional	 test	110	
system.	The	side-chain	N	of	Asn140	is	a	well-known	pharmacophoric	point	of	this	111	
epigenetic	target,12	and	defines	the	key	intermolecular	hydrogen	bond.	Again,	we	112	
observe	the	same	trend,	 i.e.	higher	WQB	 for	more	potent	 ligands,	but	with	a	 large	113	
6	
dispersion	 that	blurs	 correlation	 (Supplementary	Figures	3	 and	5).	 Interestingly,	114	
the	 lowest	 WQB	 values	 (0,	 1.1	 and	 1.7	 kcal/mol)	 correspond	 to	 three	 kinase	115	





We	then	assess	whether	 the	approach	can	be	used	 in	virtual	 ligand	screening	by	121	
testing	the	ability	of	DUck	to	distinguish	true	CDK2	ligands	from	a	set	of	carefully	122	
selected	 decoys14	 for	 which	 we	 had	 generated	 binding	 modes	 by	 docking.	 	 The	123	
distribution	 of	 WQB	 is	 strikingly	 different	 from	 the	 active	 set,	 with	 61%	 of	124	
molecules	presenting	values	below	2	kcal/mol	and	49%	below	1	kcal/mol	(Figure	125	
2A).	This	indicates	that,	in	spite	of	forming	the	key	hydrogen	bond,	this	interaction	126	
is	 labile	 for	 most	 of	 the	 docking	 decoys,	 which	 would	 translate	 to	 an	 unstable	127	
binding	mode.	We	 therefore	 propose	 that	WQB	 can	 distinguish	 true	 ligands	 from	128	
inactive	molecules,	as	shown	in	the	receiver	operating	characteristics	(ROC)	curves	129	
(Figure	2B).	To	demonstrate	the	wider	applicability	of	the	method,	we	conducted	130	
similar	 experiments	 with	 the	 adenosine	 A2A	 receptor	 (AA2R)	 and	 Trypsin,	 as	131	
representatives	 of	 G	 protein-coupled	 receptors	 (GPCR)	 and	 serine	 proteases,	132	
respectively	 (Figure	 2B).	 Together	 with	 kinases	 (such	 as	 CDK2)	 these	 protein	133	
families	include	a	large	part	of	the	current	and	investigational	drug	targets.15	The	134	
key	 hydrogen	 bonds	 tracked	 by	 the	 DUck	 simulations	 involve	 the	 side-chain	135	
carbonyl	 of	 Asn253,	 in	 the	 case	 of	 AA2R,	 and	 the	 carboxylic	 acid	 of	 Asp189,	 for	136	
Trypsin.	As	shown	in	Figure	2B,	the	results	for	these	systems	are	even	better	than	137	
for	 CDK2,	 demonstrating	 that	 DUck	 is	 surprisingly	 effective	 in	 virtual	 screening.	138	
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Importantly,	 the	 performance	 improves	 consistently	 as	 sampling	 increases,	 but	139	







and	 successful	 history	 of	 application	 in	 virtual	 screening.16,17	 Using	 the	 rDock	147	
software,18	we	 find	 that	 docking	 scores	 have	 no	 correlation	with	WQB,	 and	 good	148	
docking	scorers	are	nearly	as	 likely	to	present	a	 low	resistance	to	dissociation	as	149	
the	 rest	 of	 the	 decoys	 (Figures	 2C,	 2D	 and	 Supplementary	 Figure	 7).	 As	 such,	150	
molecular	 docking	 and	 dynamic	 undocking	 can	 be	 considered	 orthogonal	 (i.e.	151	
perfectly	complementary)	and	the	intersection	between	both	techniques	defines	a	152	
region	 highly	 enriched	 in	 true	 ligands.	 We	 have	 also	 performed	 extensive	153	




delivers	 several	 fold	 improvement	even	when	applied	 to	a	 consensus	 list	by	 two	158	
independent	 ‘thermodynamic’	 approaches	 (Figures	 2E,	 2F	 and	 Supplementary	159	
Figure	10).	These	results	 support	 the	 idea	 that	 structural	 stability	of	 the	binding	160	
mode,	just	like	good	chemical	complementarity,	is	a	necessary	–	but	not	sufficient	–	161	
condition	 for	 binding.	 By	 imposing	 both	 conditions	 simultaneously,	 we	 can	162	
multiply	 the	effectiveness	of	 structure-based	virtual	 screening.	At	 the	same	 time,	163	
8	
using	WQB	as	a	post-docking	 filter	means	 that	only	 the	best-scoring	subset	of	 the	164	




To	 demonstrate	 the	 power	 of	 the	 docking-undocking	 combination,	 we	 have	169	
applied	 the	 method	 prospectively	 for	 the	 identification	 of	 small	 molecules	 that	170	
bind	the	molecular	chaperone,	Heat	Shock	Protein	90KDa	(Hsp90).	This	oncology	171	
target	 has	 been	 a	 test-bed	 and	 paradigm	 in	 fragment	 and	 structure-based	 drug	172	
design.19	With	hundreds	of	Hsp90-ligand	complexes	deposited	in	the	Protein	Data	173	
Bank	 (PDB),	 discovery	 of	 novel	 chemotypes	 is	 very	 challenging.	 We	 focused	 on	174	
fragment-like	molecules,	 as	 this	may	 be	 the	most	 efficient	 way	 to	 discover	 new	175	
leads	and	to	generate	scaffold-hoping	ideas.20,21	A	collection	of	280000	fragment-176	
sized	molecules	was	docked	to	the	ATP	binding	site	of	Hsp90.	A	diverse	set	of	139	177	
molecules	 from	 the	 best	 450	 (top	 0.16%)	 was	 then	 selected	 and	 each	 one	 was	178	
subjected	to	100	DUck	runs	to	obtain	fully	converged	WQB	values	(note	that	fewer	179	





the	 high	 stability	 set	 (WQB	 >	 6	 kcal/mol)	 that	were	 available	 (n=21).	 They	were	185	
tested	using	 three	different	 ligand-observed	Nuclear	Magnetic	Resonance	 (NMR)	186	
experiments,	 in	 the	 absence	 or	 presence	 of	 a	 known	 competitor	 to	 confirm	 that	187	
fragment	hits	bind	at	 the	 target	site.19	Eight	out	of	 the	21	molecules	(38%)	were	188	
9	
confirmed	 as	 true	 hits	 (Table	 1).	 Crucially,	 for	 the	 same	 system	 and	 screening	189	
method,	the	hit	rate	obtained	with	a	general	fragment	screening	library	is	4.4%.22	190	
Therefore,	 the	DUck-based	virtual	screening	 increases	the	efficiency	by	nearly	an	191	




set	 (WQB	 <	 3	 kcal/mol).	 Only	 one	 molecule	 from	 these	 sets	 was	 a	 hit	 and,	196	
importantly,	its	WQB	value	is	very	close	to	the	upper	threshold	(5.6	kcal/mol).	This	197	
confirms	that	DUck	false	negatives	(i.e.	active	molecules	with	low	WQB)	are	rare,	an	198	




structures	 to	existing	Hsp90	 ligands,	 finding	 low	similarity	 in	all	 cases	 (Table	1).	203	
Binding	mode	determination	and	analysis	of	the	main	interactions	that	define	the	204	
chemical	 scaffold	 offers	 a	 more	 precise	 assessment	 of	 their	 novelty.	 Crystal	205	
structures	 for	 3	 of	 the	 fragment	 hits	 were	 determined	 by	 X-ray	 crystallography	206	
(Figure	 4	 and	 Supplementary	 Figure	 13).	 This	 confirmed	 that	 the	 docking	 pose	207	
used	 as	 starting	 position	 for	 the	 DUck	 experiments	 was	 correct,	 particularly	208	
regarding	 the	 key	 interaction	 that	 was	 being	 monitored	 (side-chain	 of	 Asp93).	209	
Compound	1	is	the	most	potent	fragment	hit	(dissociation	constant	KD=77µM)	and	210	
has	 a	 ligand	 efficiency	 (LE)	 of	 0.33	 kcal/mol	 per	 non-hydrogen	 atom,	 similar	 to	211	




advise	against	using	 this	 fragment	as	 starting	point	at	 this	 stage.	Compound	2	 is	215	
less	potent	(KD=320µM)	but	equally	efficient	(LE=0.32)	by	virtue	of	having	fewer	216	
atoms.	In	this	case,	the	key	interaction	with	Asp93	is	mediated	by	an	aminothiazole	217	
moiety,	 which	 is	 unprecedented	 and	 would	 constitute	 a	 good	 starting	 point	 to	218	
develop	new	chemical	entities.	Compound	3	(KD=700µM;	LE=0.25)	belongs	to	the	219	
well-known	 family	 of	 resorcinol	 inhibitors,	which	 includes	 the	 clinical	 candidate	220	
NVP-AUY922,19	but	provides	an	interesting	example	of	scaffold	hopping,	where	the	221	
oxime	acts	a	bioisosteric	replacement	of	the	five-membered	rings	included	as	core	222	
scaffold	 in	 the	 patents.	 Compounds	 4,	 5	 and	 6	 also	 represent	 completely	 novel	223	
starting	points,	as	their	scaffold	is	unique	amongst	Hsp90	inhibitors.	The	binding	224	
mode	 could	 not	 be	 confirmed	 experimentally,	 but	 is	 likely	 correct	 because	 two	225	








focus	 on	 binding	 free	 energy.	 Hydrogen-bonding	 groups	 in	 the	 active	 site	 are	234	
privileged	 structures	 to	 fix	 the	 ligand	 in	 place,	 particularly	 when	 they	 act	 as	235	
binding	hot	spots	and	can	form	water-shielded	hydrogen	bonds.8	The	work	needed	236	
to	break	such	interactions	(WQB)	is	very	useful	to	detect	true	ligands	even	though	it	237	
is	 a	 non-equilibrium	 property	 that	 is	 not	 expected	 to	 correlate	with	ΔGbind.	 This	238	
11	
intriguing	 fact	 may	 reflect	 the	 nature	 of	 proteins,	 which	 have	 been	 designed	 to	239	
bind	 their	 natural	 ligands	 not	 only	 with	 high	 affinity	 and	 selectivity,	 but	 also	240	
forming	 structurally	 stable	 complexes.	 Thus,	 it	 will	 be	 important	 to	 test	 the	241	
approach	 on	 other	 types	 of	 supramolecular	 assemblies.	 Dynamic	 Undocking	242	
(DUck),	 a	particular	 implementation	of	 steered	molecular	dynamics,	 allows	us	 to	243	
calculate	WQB	 in	 a	 very	 efficient	manner.	DUck	 can	be	 used	 in	 combination	with	244	
existing	‘thermodynamic’	approaches	to	multiply	their	effectiveness.	The	docking-245	
undocking	 combination	 has	 proven	 particularly	 useful	 for	 virtual	 fragment	246	
screening,	delivering	novel,	diverse	and	suitable	starting	points	with	a	hit	rate	of	247	
38%.	At	present,	we	focus	on	a	single	key	hydrogen	bond	to	estimate	WQB,	which	248	
requires	 previous	 knowledge	 and	 has	 a	 critical	 impact	 on	 the	 outcome.	 Future	249	
investigations	 should	 address	 the	 extension	 of	 the	method	 to	multiple	 sites	 and	250	
other	 interaction	 types	 to	 improve	 performance	 and	 avoid	 reliance	 on	 extrinsic	251	
decisions.	DUck	 inherits	 the	 intrinsic	 limitations	of	structure-based	methods	(e.g.	252	
protein	 flexibility,	 quality	 of	 the	 force-field)	 and	may	 have	 some	 of	 its	 own	 (e.g.	253	
long	range	effects,	steering	conditions).	Further	tests	will	reveal	its	true	potential,	254	
but	considering	that	it	is	orthogonal	to	existing	methods	and	computationally	very	255	
efficient,	 we	 expect	 that	 it	 will	 be	 rapidly	 adopted	 by	 the	 structure-based	 drug	256	








Dynamic	 Undocking	 (DUck)	 is	 a	 particular	 type	 of	 Steered	 Molecular	 Dynamics	264	
(SMD),25	where	we	force	the	rupture	of	an	intermolecular	hydrogen	bond	formed	265	
between	 a	 pre-defined	 interaction	 point	 in	 the	 receptor	 and	 a	 complementary	266	
atom	 in	 the	 ligand.	Additionally,	we	use	 a	model	 receptor	 that	 includes	 only	 the	267	
minimal	subset	of	the	protein	necessary	to	preserve	the	local	environment	around	268	






here,	 it	 can	 be	 identified	 from	 a	 structural	 superimposition	 of	 all	 the	 available	275	
protein-ligand	 complexes.	 On	 novel	 binding	 sites,	 it	 may	 be	 identified	 with	 a	276	
quantitative	 hot	 spot	 identification	 method.26.	 Then,	 the	 model	 receptor	 is	277	




are	 eliminated	 and	 truncated	 side	 chains	 are	 acetylated	 or	 N-methylated,	 as	282	
needed.	 Interstitial	 water	 molecules,	 if	 present,	 are	 preserved.	 The	 PDB	 codes,	283	
reference	 interaction	points	and	 the	 list	of	protein	residues	and	water	molecules	284	
for	 each	 system	 are	 listed	 in	 Supplementary	 Table	 3.	 Given	 the	model	 receptor	285	
13	
(protein	 chunk)	 and	 a	 set	 of	 ligands	 properly	 oriented	 (docking	 poses	 or	286	
superimposed	 X-ray	 geometries),	 a	 MOE27	 SVL	 script	 developed	 in	 house	287	
automatically	performs	the	following	steps:	1)	Calculates	AM1-BCC	charges	for	the	288	
ligand.28	2)	Assigns	parm@Frosst29	atom	types	and	non-bonded	parameters	to	the	289	
ligand.	 3)	 Identifies	 the	 ligand	 atom	 that	 is	 hydrogen-bonded	 to	 the	 protein’s	290	
reference	atom	(based	on	distance	and	type).	4)	Writes	input	and	execution	files	to	291	
carry	out	 the	MD	simulations	with	AMBER30.	5)	Calls	AMBER’s	 tLeap	to	generate	292	
valid	 topology	 and	 coordinate	 files	 for	 each	 individual	 receptor-ligand	 complex.	293	
For	 the	 protein,	 the	AMBER	 force	 field	 99SB	 is	 used.	 Each	 system	 is	 placed	 in	 a	294	
cuboid	box	spanning	at	 least	12	Å	more	than	the	furthest	atom	in	each	direction.	295	




all	 non-hydrogen	 atoms	 of	 the	 receptor	 to	 prevent	 structural	 changes.	 2)	300	
Spontaneous	rupture	of	the	key	hydrogen	bond	during	non-steered	simulations	is	301	




9Å.	 4)	 Bonds	 involving	 hydrogen	 are	 constrained	 using	 SHAKE.31	 In	 order	 to	306	
equilibrate	 the	 system	 the	 following	 steps	 are	 executed:	 1)	Energy	minimization	307	
for	1000	cycles.	2)	Assignment	of	random	velocities	at	100K	and	gradual	warming	308	
to	300K	for	400	ps	in	the	NVT	ensemble.	3)	Equilibration	of	the	system	for	1	ns	in	309	
the	NPT	ensemble	 (1	atm,	300K).	At	 this	 stage,	 the	 first	 SMD	simulations	 can	be	310	
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executed.	 We	 run	 two	 SMDs	 from	 the	 same	 restart	 file,	 but	 at	 different	311	
temperatures	(300K	and	325K)	to	ensure	that	the	trajectories	proceed	differently.	312	
The	SMD	lasts	500	ps,	during	which	time	the	distance	between	the	key	hydrogen	313	
bonds	 is	 steered	 from	2.5	Å	 to	5.0	Å	 (constant	 velocity	 of	 5	Å/ns)	with	 a	 spring	314	
constant	of	50	kcal/mol·Å2.	We	have	 tested	 slower	velocities	 and	 the	 results	 are	315	
essentially	 unchanged	 (Supplementary	 Figure	16).	 The	 spring	 constant	 had	 little	316	
influence	and	on	a	limited	test	set	we	obtained	essentially	identical	results	in	the	317	
range	 k=10	 kcal/mol·Å2	 to	 k=1000	 kcal/mol·Å2.	 We	 have	 also	 investigated	 the	318	
importance	 of	 the	 specific	 reaction	 coordinate	 by	 using	 the	 closest	 contact	319	
between	 CDK2	 Leu83:O	 and	 the	 ligand	 (instead	 of	 Leu83:N).	 The	 WQB	 values	320	
obtained	with	these	different	atoms	of	reference	(located	only	3	Å	apart)	present	a	321	
high	correlation	(r2=0.75;	Supplementary	Figure	17).	By	contrast,	when	the	atoms	322	
of	 reference	 involve	 completely	 different	 part	 of	 the	 ligand,	 the	 results	 are	323	
uncorrelated	(Supplementary	Figure	18).	 	To	generate	diverse	starting	points	 for	324	
SMD	trajectories,	we	perform	1ns	unbiased	MD	simulation	and	repeat	the	process	325	
as	 many	 times	 as	 desired	 (e.g.	 50ns	 unbiased	 MD	 simulations	 are	 needed	 to	326	
execute	 100	 SMD	 trajectories).	 All	 simulations	 were	 performed	 with	 Amber	 12	327	
adapted	 for	 running	 in	GPUs	and	executed	either	 in-house	with	NVIDIA	GeForce	328	
TITAN	 X	 GPUs	 or	 at	 the	 Barcelona	 Supercomputing	 Center	 using	 NVIDIA	 Tesla	329	




to	 obtain	 free	 energies	 from	 the	 SMD	 work,	 but	 they	 have	 strict	 convergence	334	
requirements,	are	computationally	much	more	expensive	and	the	results	are	only	335	
15	
valid	 if	 the	 reaction	 coordinate	 is	 mechanistically	 correct.25	 Instead,	 we	 simply	336	
assume	 that	 WQB	 is	 an	 upper	 limit	 to	 the	 equivalent	 magnitude	 in	 free	 energy	337	
(ΔGQB).	In	order	to	get	as	close	as	possible	to	ΔGQB,	we	run	multiple	SMD	replicas	338	
and	take	the	overall	lower	WQB	as	the	representative	value.	Note	that	we	have	used	339	




80%	 of	 candidate	 ligands	 and	 produce	 a	 reasonable	 estimate	 of	 WQB	 for	 the	344	
remaining	ones.	By	comparison,	a	high-throughput	implementation	of	MM-PBSA	(1	345	








top-scoring	 molecule	 within	 each	 cluster	 to	 select	 139	 molecules	 that	 were	354	
subjected	 to	 DUck	 simulations.	 Docking	 score	 was	 the	 main	 selection	 criterion,	355	
with	90	molecules	originating	from	the	top	200	and	all	of	them	within	the	top	450.	356	
Additional	 criteria	 included	 high	 predicted	 aqueous	 solubility	 and	 chemical	357	
diversity.	 The	 selected	 molecules	 were	 subjected	 to	 100	 DUck	 calculations.	 We	358	




the	 strong	 set.	 For	 comparison,	 we	 also	 purchased	 and	 tested	 15	 molecules	 of	362	





as	 described	 previously.32,33	 Briefly,	 a	 number	 of	 1D	 1H	NMR	 experiments	 (STD,	368	
water-LOGSY,	 relaxation	 filtered)	 were	 used	 to	 identify	 interactions	 between	369	
compounds	and	the	protein;	a	potent	competitor	(PU3)	was	then	added	in	order	to	370	




NMR	 signal	 are	 not	 necessarily	 related	 to	 binding.	 All	 NMR	 experiments	 were	375	
performed	 on	 a	 BrukerAvIII	 HD	 600	 MHz	 NMR	 spectrometer	 at	 298K;	 pulse	376	





Protein	 was	 produced	 and	 crystallized	 as	 previously	 described.35	 For	 the	382	
successful	crystals,	data	were	collected	at	100K	on	an	in-house	Bruker	D8	Venture	383	
TXS	 Generator	 with	 a	 Bruker	 Photo	 100	 detector	 and	 were	 subsequently	384	
processed	using	SAINT	&	SADABS.	The	crystals	belong	 to	 the	space	groups	 I222.	385	
17	
The	 structures	were	 solved	 by	molecular	 replacement	 using	 a	 previously	 solved	386	
Hsp90α	protein	model	(PDB	code:	1UY6;	PU3	ligand	and	solvent	removed)	and	the	387	
program	AMoRe.36	 Twenty	 cycles	 of	 rigid-body	 then	 restrained	 refinement	were	388	
carried	out	using	the	refinement	program	REFMAC537	followed	by	model	building	389	
and	solvent	addition	using	the	molecular	graphics	program	COOT.38	The	progress	390	
of	 the	 refinement	 was	 assessed	 using	 Rfree	 and	 the	 conventional	 R	 factor.	 Once	391	
refinement	was	completed	the	structures	were	validated	using	various	programs	392	
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Figure	 1.	 Calculation	 of	 WQB.	 a.	 The	 receptor	 is	 idealized	 as	 a	 model	 system	549	
containing	 only	 the	 local	 environment	 around	 a	 key	 intermolecular	 hydrogen	550	
bond.	 b.	 Representative	 work	 profiles	 obtained	 from	 dynamic	 undocking	551	
simulations	for	a	strong	(black)	and	a	weak	(grey)	ligand.	The	quasi-bound	state	is	552	




Figure	 2.	 Application	 of	 the	 quasi-bound	 approximation	 to	 ligand	 ranking.	 a.	557	
Distribution	of	WQB	values	of	potent	CDK2	 ligands	(IC50	<	1µM;	dark	grey),	weak	558	
CDK2	 ligands	 (IC50	 >	 1µM;	 light	 grey)	 and	 non-binding	 decoys	 (black).	 Points	559	
indicate	population	values,	from	which	the	smooth	lines	are	extrapolated.		b.	ROC	560	
curves	 for	 the	 CDK2	 (black),	 A2AR	 (red)	 and	 Trypsin	 (green)	 DUD	 sets.	 Plotted	561	
results	 correspond	 to	 2	 DUck	 runs	 per	 ligand.	 AUC	 values	 are	 shown	 in	562	
Supplementary	 Figure	 6.	 c.	 Docking	 score	 vs.	 WQB	 values	 for	 active	 (red)	 and	563	
inactive	 (black	 or	 gray)	 compounds	 in	 the	 CDK2	 retrospective	 virtual	 screening	564	
dataset.	 The	 quadrant	 in	 orange	 highlights	 the	 area	 corresponding	 to	 top	 25%	565	
docking	score	and	top	25%	WQB	values,	where	optimal	enrichment	factors	(EF)	are	566	
achieved.	d.	For	the	same	set,	distribution	of	WQB	values	for	the	active	compounds	567	





























































































present	 more	 scaffold	 diversity,	 make	 fewer	 peripheral	 interactions	 that	 could	
mask	the	main	interactions	and	because	Fragment-Based	Drug	Discovery	(FBDD)	










IC50	 and	 molecular	 weight	 (Supplementary	 Figure	 20).	 For	 retrospective	 VS	
experiments,	a	pool	of	30	decoys	per	active	fragment	was	obtained	with	the	DUD-E	
decoy	generator,5	which	puts	together	a	set	of	putatively	 inactive	molecules	with	
physicochemical	 properties	 very	 similar	 to	 active	 ones.	 For	 BRD4,	 as	 it	 was	
designed	to	study	the	correlation	between	experimental	binding	affinity	and	WQB,	
only	 the	 ligands	 with	 known	 binding	 mode	 and	 measured	 IC50	 or	 KD	 were	
considered	(relationship	with	molecular	weight	reported	in	Supplementary	Figure	
21).	The	crystal	structure	of	each	ligand-protein	complex	was	obtained	from	PDB	
and	used	as	 input	 for	 subsequent	 calculations.	The	 composition	of	 the	dataset	 is	
described	 in	 Supplementary	 Table	 6.	 In	 the	 case	 of	 AA2AR,	 as	 there	 are	 few	
structures	in	the	PDB,	the	active	fragments	were	taken	from	the	DUD-E	benchmark	
set.5	The	rest	of	the	procedure	is	the	same	as	described	for	CDK2.	For	Trypsin,	we	
found	 that	 few	 ligands	have	 a	 low	molecular	weight	 so	we	did	not	 filter	by	 size.	
Instead,	a	random	subset	of	2000	actives	and	decoys	was	selected	from	DUD-E.	In	











For	CDK2,	AA2AR	and	Trypsin,	 the	3D	structure	used	 to	define	 the	receptor	was	
obtained	 from	the	DUD-E	benchmark	set.5	MOE7	was	used	 to	generate	mol2	 files	
that	can	be	read	by	rDock,	our	docking	engine.8	For	Hsp90,	we	use	the	same	cavity	
definition	 and	 docking	 protocol	 described	 previously.8	 In	 all	 systems,	
pharmacophoric	restraints	were	used	to	ensure	that	the	key	interaction	point	was	
matched	by	 every	molecule	 in	 the	dataset,	 as	 defined	 in	 Supplementary	Table	 3.	
rDock	 was	 run	 with	 the	 default	 parameters	 for	 standard	 docking.	 50	 individual	
docking	processes	were	executed	per	ligand,	thus	ensuring	that	the	lowest-energy	
binding	mode	 is	 identified.	 The	 best-scoring	 solution	 is	 accepted	 as	 the	 putative	
binding	mode.	Ligands	that	do	not	fulfill	the	pharmacophore	are	identified	by	the	





the	 docking	 program	 used,	 we	 also	 run	 CDK2,	 AA2R	 and	 trypsin	 systems	 with	
Glide.9	 The	 generation	of	 the	 cavity	with	Glide	was	performed	using	 coordinates	
defined	 as	 in	 rDock	 docking	 and	 default	 parameters.	 Pharmacophoric	 restraints	
were	 defined	 to	 force	 all	 ligands	 to	 make	 a	 hydrogen	 bond	 as	 defined	 in	
Supplementary	Table	3.	Glide	docking	was	run	with	default	parameters	and	with	




MMGBSA	 and	 MMPBSA	 calculations	 using	 AMBER12	 software	 were	 also	
performed	and	compared	against	the	rest	of	methods.	Each	ligand	was	simulated	
for	 5	 ns	 with	 the	 full	 size	 receptor	 of	 CDK2	 using	 the	 same	 MD	 configuration	
defined	 in	 the	 section	 above	 (Supplementary	 Figures	 24	 and	 25).	 For	 each	
Supplementary	Information	–	Dynamic	Undocking	and	the	Quasi-Bound	State	
-	5	-	
simulation,	 a	 total	 of	 25	 snapshots	 separated	 by	 200	 ps	were	 used	 and	 the	 free	






Surface	 plasmon	 resonance	 (SPR)	 experiments	 have	 been	 done	 mainly	 as	
described	 before.11,12	 All	 measurements	 were	 performed	 on	 a	 Biacore	 T200	
instrument	(Biacore	GE	Healthcare)	at	20°C	on	Series	S	NTA	chips.	25	mM	HEPES	




injections	 of	 0.1	mg/mL	 trypsin	 and	0.5	M	 imidazole.	 	 In	 some	 experiments,	 the	




performed	 using	 BIAevaluation	 2.1	 (Biacore	 GE	Healthcare	 Bio-SciencesCorp)	 or	
Scrubber2	 (BioLogic)	 software.	 Sensorgrams	 were	 double	 referenced	 prior	 to	















































The	 macroscopic	 constants	 describing	 the	 behavior	 of	 a	 non-covalent	 complex	 are	
determined	 by	 the	 relative	 free	 energies	 of	 three	 states	 (bound,	 transition	 state	 and	
unbound).	 States	 in-between	 are	 theoretically	 irrelevant,	 so	molecules	1,	 2	 and	3	would	
have	 the	 same	 kinetic	 and	 thermodynamic	 constants.	 The	 Quasi-bound	 state	 is	 merely	























Binding	 mode	 of	 ligand	 in	 PDB	 structure	 3FZ1.	 This	 ligand	 is	 unusual	 because	 its	
interaction	 with	 the	 hinge	 region	 is	 labile.	 Structural	 and	 SAR	 data	 confirms	 that	 this	
interaction	is	not	important	for	potency.13	Instead,	this	ligand	forms	two	charge-reinforced	






30	 BRD4	 ligands	 taken	 from	 the	 PDB.	 The	 points	 in	 red	 have	 not	 been	 included	 in	 the	
correlation.	 They	 correspond	 to	 three	 kinase	 inhibitors	 that	 bind	 to	 BRD4	 as	 an	






ROC	 curves	 (left)	 and	 semilog-ROC	 curves	 (right)	 of	 the	 retrospective	 virtual	 screening	
experiments	on	CDK2	(top),	AA2R	(middle)	and	Trypsin	(bottom).	The	grey	line	indicates	
the	baseline	(random	selection).	For	CDK2,	the	results	corresponding	to	2,	8	and	22	DUck	
































Docking	 score	 vs.	WQB	 obtained	 for	 two	 different	 programs	 on	 the	 CDK2	 test	 set.	 Each	
molecule	was	docked	with	rDock	(top)	or	Glide	(bottom)	and	the	binding	mode	generated	










MMPBSA	 and	 MMGBSA-calculated	 ΔGbind	 vs.	 WQB	 on	 the	 CDK2	 test	 set.	 The	 rDock-
generated	binding	mode	was	used	as	 starting	point	 for	molecular	dynamics	 simulations,	
which	where	 then	 processed	 to	 obtain	MMPBSA	 and	MMGBSA	binding	 free	 energies.	 In	












left	 panels	 show	 a	 scatter	 plot	 of	 rDock	 score	 vs.	 Glide	 score	 (top)	 and	 rDock	 score	 vs.	













N={2,4,6,8,10,20,50}	 DUck	 runs	 and	 calculated	 the	 hit	 rates	 that	 would	 have	 been	




































Chemical	 structure	 of	 the	 tested	 compounds.	 Duck	 Class	 refers	 to	 strong,	 medium	 and	


























































































































































































































































































































































































































































































Dependence	of	 the	 results	 on	 the	 size	of	 the	 receptor.	WQB	 values	of	CDK2	 ligands	were	
calculated	 using	 the	whole	 protein	 as	 receptor	 and	 plotted	 against	 the	 results	 obtained	
with	a	truncated	system	(top).	WQB	values	obtained	with	the	truncated	system	represent	a	
lower	bound	 to	 those	obtained	with	 the	 full	 system.	This	 indicates	 that	when	 the	whole	
system	 is	 included,	 WQB	 may	 not	 reflect	 the	 contribution	 of	 the	 interaction	 under	
investigation.	 Potentially,	 this	 may	 give	 rise	 to	 false	 positives.	 Noteworthy,	 the	 virtual	




















two	different	atoms	of	 reference	 in	 the	hinge	region	of	CDK2	are	highly	correlated	(top)	
and	afford	similar	enrichment	factors	in	retrospective	virtual	screening	(bottom;	compare	
with	 Supplementary	 Figure	 8).	 The	 atoms	 used	 as	 reference	 (Leu83:N	 in	 the	 x-axis	 and	


















(Nζ  Lys33) 
1OIQ 4.48 5.18 
3BHT 6.59 9.65 
3BHV 6.94 0.00 
3EJ1 5.77 2.06 
3FZ1 0.12 10.50 
3QTQ 6.66 5.56 
3QTW 9.76 5.91 





also	 permitting	 shorter	 equilibration	 times.	 Each	 ligand	 undergoes	 equilibration	 and	 at	
least	 two	SMDs	(45	GPU	minutes).	Molecules	with	WQB	 above	a	given	 threshold	 (e.g.	 t=6	
kcal/mol)	would	 then	 proceed	 to	 N	 cycles	 of	 unbiased	MD	 +	 SMD	 simulations	 (42	 GPU	
minutes	per	cycle).	A	similar	protocol	for	MMPBSA	would	require	at	least	2	GPU	hours	of	












































DUck	 postfiltering	 improves	 early	 enrichment.	 Semilogarithmic	 ROC	 curves	 for	 the	
retrospective	 virtual	 screening	of	 CDK2,	 obtained	with	 the	best-performing	program	 for	




For	 this	 test	 set	 the	 effect	 is	most	 prominent	 in	 the	 top	 1%	 to	 5%	of	 the	 library.	 Glide-




















Examples	of	 typical	 sensorgrams	 (left	 column)	and	 steady	 state	plots	 (right	 column)	 for	
the	 binding	 of	 the	 fragment	 hits	 to	 Hsp90.	 Fragments	 were	 tested	 in	 a	 2-fold	 dilution	




































































































Number	 of	 atoms	 of	 the	 investigated	 systems.	 On	 average,	 using	 a	 protein	 chunk	 with	
explicit	 solvation	 produces	 a	 system	 20%	 in	 size	 relative	 to	 the	 whole	 protein.	 As	





Protein	 Periodic	Boxa	 Proteinb	 Periodic	Boxa,b	
Hsp90	 3291	 30387	 527	 (16,0%)	 9415	 (31,0%)	
Cdk2	 4578	 46803	 345	 (7,5%)	 9110	 (19,5%)	
AA2AR	 4603	 73039	 525	 (11,4%)	 8815	 (12,1%)	
Trypsin	 3231	 26721	 335	 (10,4%)	 9696	 (36,3%)	
















CDK2 LEU 83 NH 1CKP (A) 
ILE10 VAL18 LYS20 ALA21 VAL29 VAL30 
ALA31 LEU32 VAL64 PHE80 GLU81 PHE82 
LEU83 HIS84 GLN85 ASP86 LEU133 LEU134 
ILE135 ASN136 ALA144 
- 
AA2AR ASN 253 ND2 3EML (A) 
LEU167 PHE168 GLU169 VAL172 PRO173 
MET174 MET177 VAL178 ASN181 PHE182 
TRP246 LEU247 PRO248 LEU249 HIS250 
ILE251 ILE252 ASN253 CYS254 PHE255 
THR256 PHE257 HIS264 ALA265 PRO266 
LEU267 MET270 TYR271 LEU272 ALA273 
ILE274 
- 
Trypsin ASP189 OD1 2AYW (A) 
HIS57 LEU99 ASP102 ASP189 SER190 CYS191 
GLN192 GLY193 ASP194 SER195 VAL213 
SER214 TRP215 GLY216 SER217 GLY219 
CYS220 ALA221A GLN221 LYS224 PRO225 
GLY226 VAL227 TYR228 THR229 
1017 1096 
1098 1101 
Hsp90 ASP93 OD2 2YED (A) 
GLU47 LEU48 ILE49 SER50 ASN51 SER52 
SER53 ASP54 ALA55 LEU56 ASP57 LYS58 
ILE78 ILE91 VAL92 ASP93 THR94 GLY95 ILE96 
GLY97 MET98 GLY137 PHE138 VAL150 ILE151 




BRD4 ASN140 ND2 3U5L (A) 
TRP81 PRO82 PHE83 GLN84 GLN85 PRO86 
VAL87 ASP88 ALA89 LYS91 LEU92 ASN93 
LEU94 TYR97 ILE101 PRO104 MET105 
THR131 ASN135 CYS136 TYR137 TYR139 











Compound	 1	 2	 3	
Data	collection	statistics	
Resolution	(Ǻ)	 2.20	 2.00	 2.10	














No.	molecules/asymmetric	unit	 1	 1	 1	
Solvent	content	(%)	 57.25	 54.73	 57.41	
Measured	reflections	 66152	 66886	 62479	
Unique	reflections	 15401	 19011	 17526	
Completeness:	Overall	/	in	hrba	(%)	 99.5	/	98.5	 96.7	/	90.9b	 99.4	/	99.9	
Mean	I/σI:	Overall	/	in	hrb	 11.2	/	2.8	 11.1	/	1.3	 8.33	/	0.95	
Rmerge:	Overall	/	in	hrb	(%)	 0.083	/	0.315	 0.048	/	0.412	 0.074	/	0.555	
Refinement	statistics	
Rfree	(%)	 24.0	 30.8b	 27.6	


























List	 of	 ligands	 in	 the	 CDK2	 test	 set.	 Ligands	 highlighted	 in	 red	 are	 not	 included	 in	 the	
correlation	plotted	in	Supplementary	Figure	2	and	Supplementary	Figure	25.	
PDB No.Atoms MW IC50 (uM) Log IC50 WQB (kcal/mol) 
1E1V 21 247.303 12.00 1.08 5.53 
1E1X 22 251.292 1.30 0.11 3.19 
1JSV 23 265.293 2.00 0.30 6.93 
1JVP 19 233.274 1.60 0.20 5.59 
1OIQ 23 271.325 2.90 0.46 4.98 
1PF8 21 242.26 0.03 -1.51 6.88 
1PXJ 16 206.267 13.00 1.11 1.76 
1PXK 19 249.293 2.20 0.34 4.84 
1PXM 23 298.365 0.06 -1.22 7.32 
1VYW 24 291.355 0.04 -1.43 12.13 
1VYZ 19 227.268 0.29 -0.54 12.19 
1W0X 25 298.351 5.00 0.70 3.97 
1WCC 10 129.55 350.00 2.54 3.33 
2BTR 19 261.344 0.10 -1.02 6.50 
2BTS 24 300.417 0.02 -1.70 8.94 
2C4G 22 270.294 1.15 0.06 13.18 
2C5O 17 207.275 6.50 0.81 3.12 
2CLX 21 218.221 3.50 0.54 6.94 
2EXM 17 203.249 78.00 1.89 7.84 
2R3H 19 239.282 20.00 1.30 4.18 
2VTA 10 118.139 185.00 2.27 6.05 
2VTH 18 223.249 120.00 2.08 1.97 
2VTJ 22 286.739 1.90 0.28 1.68 
2VTL 16 187.203 97.00 1.99 7.89 
2VTM 11 144.137 1000.00 3.00 1.68 
2VTN 22 262.246 0.85 -0.07 9.11 
2VTR 16 234.67 1.50 0.18 5.34 
3BHT 20 241.255 0.01 -1.96 6.28 
3BHV 26 293.291 0.08 -1.10 7.30 
3EJ1 20 252.281 0.12 -0.92 6.41 
3FZ1 24 278.352 0.15 -0.84 0.12 
3PXY 22 233.233 5.90 0.77 3.66 
3QQK 21 259.328 15.00 1.18 7.87 
3QTQ 21 262.332 3.10 0.49 6.67 
3QTR 24 295.361 0.93 -0.03 10.90 
3QTW 24 296.349 0.65 -0.19 11.51 
3R8Z 21 262.332 49.00 1.69 6.57 
3RZB 20 236.294 100.00 2.00 9.31 
3TIY 20 220.185 17.00 1.23 3.38 
3TIZ 23 265.314 150.00 2.18 2.23 







List	 of	 ligands	 in	 the	 BRD4	 test	 set.	 Ligands	 highlighted	 in	 red	 are	 not	 included	 in	 the	
correlation	plotted	in	Supplementary	Figure	5	and	Supplementary	Figure	26.	
	
PDB No.Atoms MW IC50 or Kd (nM) Log IC50 WQB (kcal/mol) 
3MXF 31 458.00 49.00 -1.31 6.63 
3U5J 22 308.77 2460.00 0.39 7.00 
3U5L 23 323.78 640.00 -0.19 9.12 
4A9L 22 325.38 30000.00 1.48 4.78 
4C66 23 343.85 79400.00 1.90 3.92 
4CFK 23 307.35 1830.00 0.26 3.13 
4CFL 23 306.36 1330.00 0.12 3.63 
4E96 24 347.39 136.00 -0.87 4.51 
4HBV 13 241.09 23000.00 1.36 2.51 
4HBW 18 269.32 4800.00 0.68 5.98 
4HBX 20 295.36 1900.00 0.28 5.53 
4HBY 22 317.36 4400.00 0.64 5.42 
4HXR 21 338.41 4100.00 0.61 6.54 
4HXS 23 346.42 4100.00 0.61 4.90 
4J0R 22 295.34 386.00 -0.41 7.70 
4J0S 22 295.34 382.00 -0.42 7.10 
4LR6 13 174.20 33000.00 1.52 3.85 
4LZS 15 208.26 16000.00 1.20 2.84 
4MEN 20 267.33 125000.00 2.10 3.84 
4MEO 22 292.34 250000.00 2.40 5.73 
4MEQ 17 225.25 250000.00 2.40 4.62 
4O72 30 413.49 1000.00 0.00 9.00 
4O74 38 521.66 25.00 -1.60 1.67 
4O77 25 331.35 2500.00 0.40 1.10 
4O78 30 406.44 4600.00 0.66 4.07 
4O7A 23 349.17 19000.00 1.28 3.72 
4O7E 24 313.36 5700.00 0.76 0.00 
4PCE 19 253.34 7000.00 0.85 4.30 
4PCI 19 252.31 7500.00 0.88 4.84 
4UYD 15 205.22 79400.00 1.90 4.03 
	
